Herbas VPB

Print
EN | LT
LT - USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATMENT OF ATHEROSCLEROSIS
EN - USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATMENT OF ATHEROSCLEROSIS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395
A61K 39/00
European patent
(11) Number of the document 3054976
(13) Kind of document T
(96) European patent application number 14853023.1
Date of filing the European patent application 2014-10-10
(97) Date of publication of the European application 2016-08-17
(45) Date of publication and mention of the grant of the patent 2020-07-08
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/060129
Date 2014-10-10
PCT application publication
(87) Number WO 2015/054628
Date 2015-04-16
Priority applications
(30) Number Date Country code
201361889421 P 2013-10-10 US
Inventors
(72)
ZAUDERER, Maurice, US
Grantee
(73) Vaccinex, Inc., 1895 Mt. Hope Avenue, Rochester, NY 14620, US
Title
(54) USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATMENT OF ATHEROSCLEROSIS
  USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATMENT OF ATHEROSCLEROSIS
Last update date 2021-04-30